Sign in

CIK 0001661998

  • Non-accelerated filer
  • Smaller reporting company

Q32 Bio Inc.

Sign in to watch
Ticker
QTTB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473468154
Phone
+1 781-999-0232
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Former names
Q32 Bio Inc., Homology Medicines, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$320,396
in 6 filings

Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-06-15 Thistle Mary Director Grant or award · Option (Right to Buy) +18,000 18,000
2022-06-15 Gregory Richard J. Director Grant or award · Option (Right to Buy) +18,000 18,000
2022-06-15 Poulton Jeffrey V. Director Grant or award · Option (Right to Buy) +18,000 18,000
2022-06-15 REICIN ALISE Director Grant or award · Option (Right to Buy) +18,000 18,000
2022-06-15 PARMAR KUSH Director Grant or award · Option (Right to Buy) +18,000 18,000
2022-04-21 Seymour Albert Grant or award · Employee Stock Option (Right to Buy) +60,000 60,000
2022-02-24 Smith W Bradford CFO & Treasurer Grant or award · Employee Stock Option (Right to Buy) +126,000 126,000
2022-02-24 Smith W Bradford CFO & Treasurer Grant or award · Restricted Stock Units +21,000 21,000
2022-02-24 Kelly Timothy P Chief Operating Officer Grant or award · Employee Stock Option (Right to Buy) +28,200 28,200
2022-02-24 Kelly Timothy P Chief Operating Officer Grant or award · Restricted Stock Units +4,800 4,800
2022-02-24 Seymour Albert Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +128,000 128,000
2022-02-24 Seymour Albert Chief Scientific Officer Grant or award · Restricted Stock Units +21,000 21,000
2022-02-24 TZIANABOS ARTHUR President & CEO Grant or award · Employee Stock Option (Right to Buy) +350,000 350,000
2022-02-24 TZIANABOS ARTHUR President & CEO Grant or award · Restricted Stock Units +58,000 58,000
2022-01-05 Smith W Bradford CFO & Treasurer Sale −2,182 $3.78 $8K 4,418
2022-01-05 Kelly Timothy P Chief Operating Officer Sale −1,406 $3.78 $5K 2,224
2022-01-05 Seymour Albert Chief Scientific Officer Sale −1,661 $3.78 $6K 131,646
2022-01-05 Cohn Gabriel Chief Medical Officer Sale −1,661 $3.78 $6K 2,629
2022-01-05 TZIANABOS ARTHUR President & CEO Sale −5,354 $3.78 $20K 86,011
2022-01-01 Smith W Bradford CFO & Treasurer Exercise or conversion +6,600 6,600

Page 13 of 25 · 492 trades